BIOCRYST PHARMACEUTICALS, INC. Interest Expense
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Interest Expense of $24.73 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-06.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-08-06
- BIOCRYST PHARMACEUTICALS, INC. interest expense for the quarter ending 2024-06-30 was $24.73M, a 14.46% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. interest expense for the quarter ending 2024-03-31 was $24.51M, a 10.55% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-12-31 was $24.58M, a 7.09% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-09-30 was $27.34M, a 10.37% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. interest expense for fiscal 2023 was $108.24M, a 9.23% increase from fiscal 2022.
- BIOCRYST PHARMACEUTICALS, INC. interest expense for fiscal 2022 was $99.09M, a 67.12% increase from fiscal 2021.
- BIOCRYST PHARMACEUTICALS, INC. interest expense for fiscal 2021 was $59.29M, a 308.90% increase from fiscal 2020.
- BIOCRYST PHARMACEUTICALS, INC. interest expense for fiscal 2020 was $14.50M, a 21.94% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $24.73M 10-Q · filed 2024-08-06 | $49.24M 10-Q · filed 2024-08-06 | $73.82M derived: sum of 3 quarters · filed 2024-08-06 | $101.17M derived: sum of 4 quarters · filed 2024-08-06 |
| 2024-03-31 | $24.51M 10-Q · filed 2024-05-07 | $49.09M derived: sum of 2 quarters · filed 2024-05-07 | $76.43M derived: sum of 3 quarters · filed 2024-05-07 | $105.35M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-12-31 | $24.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $51.93M derived: sum of 2 quarters · filed 2024-02-27 | $80.84M derived: sum of 3 quarters · filed 2024-08-06 | $108.24M 10-K · filed 2024-02-27 |
| 2023-09-30 | $27.34M 10-Q · filed 2023-11-08 | $56.26M derived: sum of 2 quarters · filed 2024-08-06 | $83.66M 10-Q · filed 2023-11-08 | $110.11M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-06-30 | $28.91M 10-Q · filed 2024-08-06 | $56.31M 10-Q · filed 2024-08-06 | $82.77M derived: sum of 3 quarters · filed 2024-08-06 | $107.54M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $27.40M 10-Q · filed 2024-05-07 | $53.85M derived: sum of 2 quarters · filed 2024-05-07 | $78.63M derived: sum of 3 quarters · filed 2024-05-07 | $102.65M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $26.46M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $51.23M derived: sum of 2 quarters · filed 2024-02-27 | $75.25M derived: sum of 3 quarters · filed 2024-02-27 | $99.09M 10-K · filed 2024-02-27 |
| 2022-09-30 | $24.77M 10-Q · filed 2023-11-08 | $48.80M derived: sum of 2 quarters · filed 2023-11-08 | $72.63M 10-Q · filed 2023-11-08 | $91.41M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $24.02M 10-Q · filed 2023-08-07 | $47.86M 10-Q · filed 2023-08-07 | $66.64M derived: sum of 3 quarters · filed 2024-02-27 | $80.75M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $23.84M 10-Q · filed 2023-05-08 | $42.62M derived: sum of 2 quarters · filed 2024-02-27 | $56.73M derived: sum of 3 quarters · filed 2024-02-27 | $70.23M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $18.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $32.90M derived: sum of 2 quarters · filed 2024-02-27 | $46.39M derived: sum of 3 quarters · filed 2024-02-27 | $59.29M 10-K · filed 2024-02-27 |
| 2021-09-30 | $14.12M 10-Q · filed 2022-11-04 | $27.61M derived: sum of 2 quarters · filed 2022-11-04 | $40.51M 10-Q · filed 2022-11-04 | $46.12M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $13.49M 10-Q · filed 2022-08-05 | $26.40M 10-Q · filed 2022-08-05 | $32.01M derived: sum of 3 quarters · filed 2023-02-27 | $34.94M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $12.90M 10-Q · filed 2022-05-09 | $18.51M derived: sum of 2 quarters · filed 2023-02-27 | $21.44M derived: sum of 3 quarters · filed 2023-02-27 | $24.36M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $5.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $8.54M derived: sum of 2 quarters · filed 2023-02-27 | $11.45M derived: sum of 3 quarters · filed 2023-02-27 | $14.50M 10-K · filed 2023-02-27 |
| 2020-09-30 | $2.93M 10-Q · filed 2021-11-04 | $5.84M derived: sum of 2 quarters · filed 2021-11-04 | $8.89M 10-Q · filed 2021-11-04 | $11.98M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $2.92M 10-Q · filed 2021-08-09 | $5.96M 10-Q · filed 2021-08-09 | $9.05M derived: sum of 3 quarters · filed 2022-02-28 | $12.10M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $3.05M 10-Q · filed 2021-05-07 | $6.13M derived: sum of 2 quarters · filed 2022-02-28 | $9.18M derived: sum of 3 quarters · filed 2022-02-28 | $12.21M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $6.13M derived: sum of 2 quarters · filed 2022-02-28 | $9.17M derived: sum of 3 quarters · filed 2022-02-28 | $11.89M 10-K · filed 2022-02-28 |
| 2019-09-30 | $3.04M 10-Q · filed 2020-11-06 | $6.08M derived: sum of 2 quarters · filed 2020-11-06 | $8.80M 10-Q · filed 2020-11-06 | $11.22M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $3.04M 10-Q · filed 2020-08-07 | $5.76M 10-Q · filed 2020-08-07 | $8.18M derived: sum of 3 quarters · filed 2021-03-01 | $10.52M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $2.73M 10-Q · filed 2020-05-11 | $5.14M derived: sum of 2 quarters · filed 2021-03-01 | $7.49M derived: sum of 3 quarters · filed 2021-03-01 | $9.68M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $2.41M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $4.76M derived: sum of 2 quarters · filed 2021-03-01 | $6.96M derived: sum of 3 quarters · filed 2021-03-01 | $9.18M 10-K · filed 2021-03-01 |
| 2018-09-30 | $2.35M 10-Q · filed 2019-11-08 | $4.54M derived: sum of 2 quarters · filed 2019-11-08 | $6.76M 10-Q · filed 2019-11-08 | $8.99M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | $2.19M 10-Q · filed 2019-08-08 | $4.42M 10-Q · filed 2019-08-08 | $6.65M derived: sum of 3 quarters · filed 2020-03-13 | $8.79M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | $2.22M 10-Q · filed 2019-05-09 | $4.45M derived: sum of 2 quarters · filed 2020-03-13 | $6.59M derived: sum of 3 quarters · filed 2020-03-13 | $8.69M derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $4.37M derived: sum of 2 quarters · filed 2020-03-13 | $6.46M derived: sum of 3 quarters · filed 2020-03-13 | $8.56M 10-K · filed 2020-03-13 |
| 2017-09-30 | $2.14M 10-Q · filed 2018-11-08 | $4.23M derived: sum of 2 quarters · filed 2018-11-08 | $6.33M 10-Q · filed 2018-11-08 | $8.46M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-06-30 | $2.09M 10-Q · filed 2018-08-09 | $4.19M 10-Q · filed 2018-08-09 | $6.33M derived: sum of 3 quarters · filed 2019-03-14 | $7.79M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-03-31 | $2.10M 10-Q · filed 2018-05-09 | $4.23M derived: sum of 2 quarters · filed 2019-03-14 | $5.70M derived: sum of 3 quarters · filed 2019-03-14 | $7.12M derived: sum of 4 quarters · filed 2019-03-14 |
| 2016-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $3.60M derived: sum of 2 quarters · filed 2019-03-14 | $5.02M derived: sum of 3 quarters · filed 2019-03-14 | $6.49M 10-K · filed 2019-03-14 |
| 2016-09-30 | $1.47M 10-Q · filed 2017-11-08 | $2.89M derived: sum of 2 quarters · filed 2017-11-08 | $4.36M 10-Q · filed 2017-11-08 | $5.69M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $1.42M 10-Q · filed 2017-08-08 | $2.89M 10-Q · filed 2017-08-08 | $4.23M derived: sum of 3 quarters · filed 2018-03-12 | $5.47M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $1.47M 10-Q · filed 2017-05-08 | $2.81M derived: sum of 2 quarters · filed 2018-03-12 | $4.05M derived: sum of 3 quarters · filed 2018-03-12 | $5.36M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $2.58M derived: sum of 2 quarters · filed 2018-03-12 | $3.88M derived: sum of 3 quarters · filed 2018-03-12 | $5.20M 10-K · filed 2018-03-12 |
| 2015-09-30 | $1.24M 10-Q · filed 2016-11-08 | $2.55M derived: sum of 2 quarters · filed 2016-11-08 | $3.86M 10-Q · filed 2016-11-08 | $5.18M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $1.31M 10-Q · filed 2016-08-08 | $2.62M 10-Q · filed 2016-08-08 | $3.94M derived: sum of 3 quarters · filed 2017-02-27 | $5.15M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $1.31M 10-Q · filed 2016-05-09 | $2.63M derived: sum of 2 quarters · filed 2017-02-27 | $3.85M derived: sum of 3 quarters · filed 2017-02-27 | $5.07M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $2.53M derived: sum of 2 quarters · filed 2017-02-27 | $3.76M derived: sum of 3 quarters · filed 2017-02-27 | $5.00M 10-K · filed 2017-02-27 |
| 2014-09-30 | $1.22M 10-Q · filed 2015-11-06 | $2.44M derived: sum of 2 quarters · filed 2015-11-06 | $3.68M 10-Q · filed 2015-11-06 | $4.93M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $1.23M 10-Q · filed 2015-08-07 | $2.47M 10-Q · filed 2015-08-07 | $3.71M derived: sum of 3 quarters · filed 2016-02-26 | $4.90M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $1.24M 10-Q · filed 2015-05-08 | $2.48M derived: sum of 2 quarters · filed 2016-02-26 | $3.67M derived: sum of 3 quarters · filed 2016-02-26 | $4.84M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $2.43M derived: sum of 2 quarters · filed 2016-02-26 | $3.60M derived: sum of 3 quarters · filed 2016-02-26 | $4.78M 10-K · filed 2016-02-26 |
| 2013-09-30 | $1.19M 10-Q · filed 2014-11-07 | $2.36M derived: sum of 2 quarters · filed 2014-11-07 | $3.54M 10-Q · filed 2014-11-07 | $4.72M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $1.17M 10-Q · filed 2014-08-08 | $2.35M 10-Q · filed 2014-08-08 | $3.52M derived: sum of 3 quarters · filed 2015-03-02 | $4.69M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $1.18M 10-Q · filed 2014-05-09 | $2.36M derived: sum of 2 quarters · filed 2015-03-02 | $3.53M derived: sum of 3 quarters · filed 2015-03-02 | $4.69M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $2.35M derived: sum of 2 quarters · filed 2015-03-02 | $3.51M derived: sum of 3 quarters · filed 2015-03-02 | $4.67M 10-K · filed 2015-03-02 |
| 2012-09-30 | $1.17M 10-Q · filed 2013-11-08 | $2.33M derived: sum of 2 quarters · filed 2013-11-08 | $3.49M 10-Q · filed 2013-11-08 | $4.65M derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-06-30 | $1.16M 10-Q · filed 2013-08-08 | $2.32M 10-Q · filed 2013-08-08 | $3.48M derived: sum of 3 quarters · filed 2014-03-10 | $4.64M derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-03-31 | $1.16M 10-Q · filed 2013-05-09 | $2.32M derived: sum of 2 quarters · filed 2014-03-10 | $3.48M derived: sum of 3 quarters · filed 2014-03-10 | $4.65M derived: sum of 4 quarters · filed 2014-03-10 |
| 2011-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | $2.32M derived: sum of 2 quarters · filed 2014-03-10 | $3.49M derived: sum of 3 quarters · filed 2014-03-10 | $3.77M 10-K · filed 2014-03-10 |
| 2011-09-30 | $1.16M 10-Q · filed 2012-11-08 | $2.33M derived: sum of 2 quarters · filed 2012-11-08 | $2.61M 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $1.17M 10-Q · filed 2012-08-08 | $1.46M 10-Q · filed 2012-08-08 | ||
| 2011-03-31 | $288.00K 10-Q · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |